7D Surgical's largest financing round to bolster product development, expansion plans

Alan Condon -   Print  | Email

7D Surgical has completed its largest financing round to date, according to a Sept. 15 announcement.

Five things to know:

1. The spine device company aims to use the capital for product development, international expansion and operational growth. The amount of capital raised was not disclosed by the company.

2. In July, 7D Surgical received regulatory approval for the Machine-vision Image Guided Surgery system, its flagship device, in Europe and Singapore.

3. MvIGS has already launched in the U.S., Canada, Australia, New Zealand and the Caribbean, and will enter the European market later this year.

4. The device is designed to replace standard fluoroscopy and offers a radiation-free tool to place spinal implants.

5. MvIGS uses visible light that allows surgeons to register spinal segments in seconds, which reduces operating room time and eliminates intraoperative radiation exposure.

More articles on devices:
The evolution of MIS SI joint: 6 key developments since CMS upped rates 27%
Losing its orthopedic provider to a competitor, New York system taps new partner
Orthopedic rankings, robotics & more: 6 key developments at Mayo Clinic during the pandemic

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.